Skip to content

Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft

The Analgesic Efficacy of the Transversalis Fascia Plane Block in Iliac Crest Bone Graft Harvesting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01133730
Enrollment
56
Registered
2010-05-31
Start date
2010-08-31
Completion date
2012-12-31
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Limb Surgery, Iliac Crest Bone Harvest

Keywords

supraclavicular nerve block, regional anesthesia, transversalis fascia plane block, ultrasound guided, opioid consumption, iliac crest bone harvest, hand surgery, wrist surgery, Upper limb surgery combined with iliac crest bone harvest.

Brief summary

Hand or wrist surgery often requires the use of bony material in order to accomplish any associated reconstructive aspects required for the surgery. The iliac crest is often used as the source of bone for such surgery and harvesting from this site is performed simultaneously with the hand/wrist surgery. In terms of anesthesia, patients typically receive a supraclavicular nerve block for the hand/wrist surgery, and a general anesthestic for the bone graft, though spinal block may also be performed. This study will look at the use of a transversalis fascia plane (TFP) nerve block (ie, to numb the nerves going to the iliac crest) in combination with a general anesthetic to see if post-operative pain and opioid consumption is reduced using the TFP block.

Interventions

DRUGPlacebo Arm

US-guided TFP block with 20ml of 5% dextrose solution

US-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. ASA physical status I-III 2. 18-85 years of age, inclusive 3. Weight 50kg+ 4. Scheduled for elective upper limb surgery, which can be solely performed under a brachial plexus block, and requiring an ICBG

Exclusion criteria

1. Contraindications to regional blockade (e.g., allergy to local anesthetics, coagulopathy, malignancy or infection in the area) 2. Pregnancy 3. History of alcohol or drug dependency/abuse 4. History of long term opioid intake or chronic pain disorder 5. History of significant psychiatric conditions that may affect patient assessment 6. Failure of upper extremity block 7. Previous iliac crest bone grafting 8. History of severe pelvic and hip conditions that could interfere with the long-term functional assessments of the study 9. Inability to understand the informed consent and demands of the study.

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumption24 hoursOpioid consumption in the first 24 hours following ICBG. This will be expressed in terms of milligrams doses of IV morphine. Where other opioids are used, the doses will be converted to the equivalent IV morphine dose using standard opioid dosage conversion tables.

Secondary

MeasureTime frameDescription
Opioid consumption7 daysOpioid consumption (expressed as milligram doses of IV morphine) in the following phases * Intraoperative phase (from start of surgery to end of surgery) * Postoperative care unit stay (from admission to discharge) * First 48 hours following ICBG
Pain measures48 hours* Pain scores at the ICBG site, measured using a visual analogue scale (VAS) (scale 0-10) and starting in recovery, then every 4 hrs for the next 48 hrs. * Pain at the primary surgical site (VAS 0-10) * Duration of block, defined as the time from completion of block performance to the time of onset of increased pain at the ICBG harvest site (as perceived by the patient)
Time of block performance6 hoursTime required to perform the TFP block (defined as the time between placement of the ultrasound probe on the patient, and withdrawal of the block needle)
Complications12 monthsTFP block complications and adverse events (e.g. vascular puncture, intravascular local anesthetic injection and local hematoma)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026